A 34-year-old man comes to the clinic for a follow-up examination of poorly controlled hypertension. He was diagnosed with hypertension two years ago and is currently taking amlodipine, lisinopril, and hydrochlorothiazide at maximally tolerated doses. He reports no headaches, chest pain, palpitations, or abnormal sweating. His blood pressure is mm Hg, and his pulse is /min. His BMI is kg/m . Physical examination shows no abdominal bruits, delayed femoral pulses, or cushingoid features. Laboratory studies reveal:
Sodium: mEq/L
Potassium: mEq/L
Chloride: mEq/L
Bicarbonate: mEq/L
Creatinine: mg/dL
Which of the following is the most appropriate next step in the diagnostic workup of this patient?
- Measurement of plasma aldosterone concentration and plasma renin activityAnswer
- BAdrenal venous sampling
- COral sodium loading test
- DNoncontrast CT scan of the abdomen
- ERenal duplex ultrasonography
Answer
Measurement of plasma aldosterone concentration and plasma renin activity
The correct answer is measurement of plasma aldosterone concentration and plasma renin activity. This patient presents with resistant hypertension (blood pressure mm Hg despite adherence to three antihypertensive medications of different classes, including a diuretic) and significant spontaneous hypokalemia. This clinical picture is highly suspicious for primary hyperaldosteronism. The diagnostic algorithm for primary hyperaldosteronism follows a strict sequential framework: initial screening, biochemical confirmation, and finally, subtype classification (localization). The most appropriate initial screening test is the early morning plasma aldosterone concentration (PAC) to plasma renin activity (PRA) ratio (ARR). A high ARR (typically ) with a PAC ng/dL suggests the diagnosis and prompts confirmatory testing.
Step-by-Step Solution
Key Concept
The diagnostic workup for primary hyperaldosteronism requires step-wise progression starting with an aldosterone-to-renin ratio (ARR) screening, followed by confirmatory testing (e.g., oral sodium loading), and finally localization (e.g., CT scan and adrenal venous sampling).